Metabolic phenotypes are the products of interactions among a variety of factors-dietary, other lifestyle/environmental, gut microbial and genetic [1] [2] [3] . We use a large-scale exploratory analytical approach to investigate metabolic phenotype variation across and within four human populations, based on 1 H NMR spectroscopy. Metabolites discriminating across populations are then linked to data for individuals on blood pressure, a major risk factor for coronary heart disease and stroke (leading causes of mortality worldwide 4 ). We analyse spectra from two 24-hour urine specimens for each of 4,630 participants from the INTERMAP epidemiological study 5 , involving 17 population samples aged 40-59 in China, Japan, UK and USA. We show that urinary metabolite excretion patterns for East Asian and western population samples, with contrasting diets, diet-related major risk factors, and coronary heart disease/stroke rates, are significantly differentiated (P , 10 216 ), as are Chinese/Japanese metabolic phenotypes, and subgroups with differences in dietary vegetable/animal protein and blood pressure 6 . Among discriminatory metabolites, we quantify four and show association (P , 0.05 to P , 0.0001) of mean 24-hour urinary formate excretion with blood pressure in multiple regression analyses for individuals. Mean 24-hour urinary excretion of alanine (direct) and hippurate (inverse), reflecting diet and gut microbial activities 2,7 , are also associated with blood pressure of individuals. Metabolic phenotyping applied to highquality epidemiological data offers the potential to develop an area of aetiopathogenetic knowledge involving discovery of novel biomarkers related to cardiovascular disease risk.
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Prehypertensive and hypertensive blood pressure (BP) is prevalent among a majority of middle-aged and older adults in most countries, and is a major risk factor perpetuating the cardiovascular disease epidemic 8 . The goal of the INTERMAP metabonomic study 1 is to develop metabolic phenotyping approaches to elucidate aetiopathogenetic mechanisms underlying the global BP problem and related disorders 8 . It aims to identify urinary metabolites that discriminate across population/subgroup strata defined by geographic or dietary criteria, and assess-for individuals-independent relationships of these metabolites to BP. The basic concepts are: (1) for population/ subgroup strata with differing coronary heart disease (CHD)/stroke rates or BP levels, the differences are largely attributable to lifestyles, especially diet; (2) these differences across strata are reflected in urinary metabolite patterns and specific metabolic biomarkers; and (3) for individuals, these biomarkers may relate independently to their BP. We use a technology platform that is analytically unbiased and detects a wide variety of metabolites from dietary, gut microbial and host metabolism sources in one analytical sweep 1 , thus maximizing opportunity for novel biomarker discovery. The numbers of individuals in our population samples are as follows: China, n 5 832; Japan, n 5 1,138; UK, n 5 496; and USA, n 5 2,164.
A schematic summarizing data-analysis strategy is shown in Supplementary Fig. 1a, b . From hierarchical clustering analysis (HCA) with group average linkage applied to the probabilistic quotient normalized 9 median 1 H NMR spectrum (Methods), we find that East Asian and western populations have well-differentiated metabolic phenotypes (Fig. 1) . Results for first and second urine specimens show highly similar clustering order ( Fig. 1 and Supplementary Fig. 2a ), as do HCA dendrograms generated using the single-linkage method ( Supplementary  Fig. 2b, c) . Geographic metabolic differences are greater than gender differences. Metabolic phenotypes of southern (Guangxi) and northern (Beijing and Shanxi) Chinese are also differentiated; those of UK and USA population samples overlap. These findings are consistent with principal components analysis (PCA) results ( Fig. 2a-d and Supplementary Fig. 3a-d ). The plots of PCA scores show similarity of median urine metabolite profiles by gender, with separate subclusters for China (north and south), Japan and the two western population samples. Analyses of spectroscopic data sets from first and second urine specimens are highly consistent ( Supplementary Fig. 4a ), as are analyses limited to normal weight, non-diabetic participants ( Supplementary  Fig. 4b ), and analyses repeated after removal of metabolic outliers (individual data shown in Supplementary Fig. 5 ) using the 95% Hotelling's T 2 statistic 10 (Methods and Supplementary Fig. 6a , b). We examine pairwise comparisons across countries (except for UK and USA which are poorly discriminated) and show significant differences (Hotelling's T 2 , P , 10 216 ) using orthogonally filtered partial least squares discriminant analysis (O-PLS-DA) 11 , after exclusion of metabolic outliers. Japanese living in Japan and JapaneseAmericans are also differentiated (P , 10 216 ). Discriminatory metabolites (Supplementary Table 1a , b) are identified from the O-PLS-DA coefficients on the basis of four criteria: P value, the rank of the P value, stability of rank and regression coefficient strength from a bootstrap resampling procedure (Methods). They include metabolites of predominantly dietary origin, for example, amino acids, creatine and trimethylamine-N-oxide; compounds related to energy metabolism (acetylcarnitine, tricarboxylic acid cycle intermediates); and dicarboxylic acids (for example, suberate). We also find that population gut microbial-mammalian co-metabolites 2 are discriminatory, for example, hippurate, phenylacetylglutamine and methylamines; we have previously shown structural differences in Chinese and American gut microbial speciation and direct linkage of microbial composition to metabolic phenotype 12 . Participants consuming dietary protein predominantly from vegetable or from animal sources (subgroups differing in BP levels 6 ) are also differentiated (Hotelling's T 2 P , 10 213 ) for East Asian and western samples considered separately (Fig. 3a, b and Supplementary  Fig. 7a, b ). Significant discriminatory metabolites (Fig. 3c, d and Supplementary Fig. 7c,d ) closely correspond to those from the pairwise country comparisons.
We then quantify four discriminatory metabolites (alanine, formate, hippurate and N-methylnicotinate) from the 1 H NMR spectra (Methods and Supplementary Fig. 1b ) and analyse these with respect to all other spectral variables using O-PLS regression 11 . Largest r 2 values (first urine specimens), other than for intra-molecular correlations, are (1) for alanine, with 2-oxoglutarate, reflecting close metabolic linkage via glutamate-pyruvate transaminase activity 13 ; (2) for formate, with alanine, explained by pyruvate/Co-A metabolism; (3) for hippurate with N-methylnicotinate; and (4) for N-methylnicotinate with hippurate, reflecting common or related renal transporter/secretion mechanisms. We also find significant correlations (jrj $ 0.10, P , 10
29
) with other variables (Supplementary Table 2 , we find significant inverse associations of formate with both systolic and diastolic BP (all eight models, Table 1 ); also of hippurate in six models, and a significant direct association of alanine with BP in five models (Table 1) . Regression estimates are similar or larger with analyses restricted to 'non-intervened' individuals 16 , that is, people without special diet/nutritional supplements or diagnosis/treatment for cardiovascular disease or diabetes (Supplementary Table 3 ). Technical errors and reliability estimates of quantified metabolites are provided in Supplementary Information and Supplementary Table 4 .
Using large-scale metabolic phenotyping, we have identified novel candidate urinary biomarkers related to BP. Endogenous formate is largely the product of one-carbon metabolism via the activities of mitochondrial and cytosolic serine hydroxymethyl transferases, and the tetrahydrofolate pathway 17 . Formate is also produced as one byproduct of fermentation of dietary fibre by the gut microbiome 18 . It is involved in active Cl 2 reabsorption at the apical proximal tubule via the CFEX anion exchanger under inhibitory control of the serinethreonine kinase WNK4; gain-of-function mutations in WNK4 cause pseudohypoaldosteronism type II, a mendelian disorder associated with hypertension 19 . We show that urinary formate and urinary Na 1 excretion are positively correlated. Given the central importance of NaCl in control of BP and the rise of BP with age 15, 20 , our findings suggest a previously unrecognized role for formate in BP regulation.
The inverse association of hippurate (benzoyl glycine) with BP may reflect physiological connections with diet 7 and gut microbial activity 2 . Availability of calories from the diet is also modulated by gut microbes in human obesity 21 , which in turn relates to BP 15 . We previously reported that dietary alanine is higher in people consuming a predominantly animal compared with a predominantly vegetable diet 6 , consistent with our findings here of a direct association of urinary alanine excretion with BP. Also in experimental animal models, alanine modulates cardiovascular responses to circulating catecholamines and increases BP 22 . Cross-population metabolic differences shown here add a new dimension to the decades-long knowledge of East-West contrasting patterns of diet, diet-related major risk factors and CHD/stroke mortality ( Supplementary Information, Supplementary Figs 8a, b and 9a , b, and Supplementary Tables 5 and 6 ). We have shown that urinary metabolic phenotyping across populations/subgroups at differing risks of CHD/stroke and high BP identifies novel candidate biomarkers that relate to BP of individuals. This may provide the basis for a new 'metabolome-wide association' approach in molecular epidemiology to help understand the complex interactions of lifestyles, environment and genes that determine major diseases in the twentyfirst century.
METHODS SUMMARY
INTERMAP is an international standardized population-based epidemiological investigation of diet and BP 5 . We collected four in-depth 24-h multi-pass dietary recalls, eight BP measurements, anthropometric and questionnaire data and obtained two timed 24-h urine specimens, on average three weeks apart, from each individual according to standard protocol. We performed 600 MHz 1 H NMR spectroscopy on these samples; estimated within-specimen reproducibility was .98% from blinded analysis of 8% specimens split in the field 1 . Scans (64) for each spectrum were acquired using standard parameters and pre-processing algorithms 23 ; spectra were reduced to 7,100 variables by integrating spectral intensity in segments (width in chemical shift d, 0.001) corresponding to the regions d 5 0.5-9.5 (excluding d 5 4.5-6.4 containing the residual water and urea resonances). We performed HCA and PCA using the median NMR spectrum for each of 34 gender-specific population samples. The Hotelling T 2 statistic (95% criterion) 10 , calculated from PCA analyses of all first and second 24-h urine spectra, was used to remove metabolic outliers (n 5 575), enabling finer spectral detail. For the remaining 4,055 individuals, we used O-PLS-DA 11 to detect patterns of metabolites differentiating pairs of populations/subgroups. All models were computed separately for first and second 24-h urine specimens. For four quantified metabolites, we estimated technical error 5 from the 8% split samples and intra-individual reliability 24 from comparison of first and second 24-h urinary excretion values. Correlation-regression analyses were performed using standard methods 6 .
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. 
